Genetic variants in m5C modification coding genes were associated with enhanced pediatric ALL susceptibility and suggested that NOL1 and NSUN4 gene polymorphisms might be a potential liquid biopsy biomarker for pediatric ALL. This evidence concerns the gene NSUN5 and acute lymphoblastic leukemia.